SARS-CoV-2 Spike enters host cells by binding to its receptor human angiotensin-converting enzyme 2 (hACE2) through its receptor-binding domain (RBD) [73] in some COVID-19 patients [74,79]. This evidence concerns the gene ACE2 and COVID-19.